Growth Metrics

Exagen (XGN) Operating Income (2018 - 2025)

Exagen's Operating Income history spans 8 years, with the latest figure at -$5.0 million for Q4 2025.

  • For Q4 2025, Operating Income fell 47.06% year-over-year to -$5.0 million; the TTM value through Dec 2025 reached -$14.1 million, down 3.18%, while the annual FY2025 figure was -$14.1 million, 3.18% down from the prior year.
  • Operating Income reached -$5.0 million in Q4 2025 per XGN's latest filing, down from -$3.1 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of -$2.6 million in Q2 2024 to a low of -$14.5 million in Q4 2022.
  • Average Operating Income over 5 years is -$6.0 million, with a median of -$5.1 million recorded in 2023.
  • Peak YoY movement for Operating Income: crashed 144.93% in 2022, then skyrocketed 65.05% in 2023.
  • A 5-year view of Operating Income shows it stood at -$6.3 million in 2021, then plummeted by 131.71% to -$14.5 million in 2022, then surged by 64.48% to -$5.1 million in 2023, then soared by 34.27% to -$3.4 million in 2024, then crashed by 47.06% to -$5.0 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Operating Income are -$5.0 million (Q4 2025), -$3.1 million (Q3 2025), and -$2.6 million (Q2 2025).